Tobacco use and cancer risk in the agricultural health study

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 5, 2017, Pages 769-778

  Andreotti, Gabriella ^a   Freedman, Neal D ^a   Silverman, Debra T ^a   Lerro, Catherine C ^a   Koutros, Stella ^a   Hartge, Patricia ^a   Alavanja, Michael C ^a   Sandler, Dale P ^b   Freeman, Laura Beane ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGRICULTURE; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CHEWING TOBACCO; COHORT ANALYSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DRINKING BEHAVIOR; FEMALE; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKELESS TOBACCO; SMOKING; TOBACCO USE; UNITED STATES; UROGENITAL TRACT CANCER; INCIDENCE; MIDDLE AGED; NEOPLASM; RISK FACTOR; TOBACCO;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS; TOBACCO PRODUCTS; TOBACCO USE; UNITED STATES;

EID: 85019262720     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0748     Document Type: Article

References (44)

1. Agaku IT, King BA, Husten CG, Bunnell R, Ambrose BK, Hu SS, et al. Tobacco product use among adults-United States, 2012-2013. MMWR Morb Mortal Wkly Rep 2014;63:542-7.
2. National Cancer Institute and Centers for Disease Control and Prevention. Smokeless tobacco and public health: a global perspective. Bethesda, MD: NIH.
3. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: summary of national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration.
4. McClave AK, Whitney N, Thorne SL,Mariolis P, Dube SR, EngstromM, et al. Centers for Disease Control and Prevention (CDC). Adult tobacco survey-19 States, 2003-2007. MMWR Surveill Summ 2010;59:1-75.
5. American Cancer Society. Cancer facts & figures 2014. Atlanta, GA: American Cancer Society; 2014.
6. U. S. Department of Health and Human Services. The health consequences of smoking-50 years of progress: a report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2014.
7. Jacobs EJ, Newton CC, Carter BD, Feskanich D, Freedman ND, Prentice RL, et al. What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking? Ann Epidemiol 2015;25:179-82.
8. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009;10:1033-34
9. Alavanja MC, Sandler DP, McMaster SB, Zahm SH, McDonnell CJ, Lynch CF, et al. The Agricultural Health Study. Environ Health Perspect 1996; 104:362-69.
10. Alavanja MC, Dosemeci M, Samanic C, Lubin J, Lynch CF, Knott C, et al. Pesticides and lung cancer risk in the agricultural health study cohort. Am J Epidemiol 2004;160:876-85.
11. Koutros S, Alavanja MC, Lubin JH, Sandler DP, Hoppin JA, Lynch CF, et al. An update of cancer incidence in the Agricultural Health Study. J Occup Environ Med 2010;52:1098-1105.
12. Spitz MR, Wu X, Wilkinson A, Wei Q. Cancer of the lung. In: Fraumeni JFJr, editors. Cancer epidemiology and prevention. 3rd ed. Oxford, United Kingdom: Oxford University Press; 2006. p. 638-58.
13. Vineis P, Kogevinas M, Simonato L, Brennan P, Boffetta P. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res 2000;463:103-10.
14. Flanders WD, Lally CA, Zhu BP, Henley SJ, Thun MJ. Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. Cancer Res 2003;63:6556-62.
15. Lubin JH, Caporaso N. Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev 200S6; 15:517-23.
16. Yuan JM, Butler LM, Stepanov I, Hecht SS. Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer. Cancer Res 2014; 74:401-11.
17. Boffetta P, Nyberg F, Agudo A, Fortes C, Gonzalez CA, Pershagen G. Risk of lung cancer from exposure to environmental tobacco smoke from cigars, cigarillos and pipes. Int J Cancer 1999;83:805-6.
18. Gerlach KK, Cummings KM, Hyland A, Gilpin EA, Johnson MD, Pierce JP. Trends in cigar consumption and smoking prevalence. In: Shopland DR, Burns DM, Hoffmann D, editors. Smoking and Tobacco Control Monograph No. 9: Cigars: Health Effects and Trends, Bethesda, MD: U. S. Department of Health and Human Services, National Cancer Institute, 1998.
19. Pitard A, Brennan P, Clavel J, Greiser E, Lopez-Abente G, Chang-Claude J, et al. Cigar, pipe, and cigarette smoking and bladder cancer risk in European men. Cancer Causes Control 2001;12:551-6.
20. McCormack VA, Agudo A, Dahm CC, Overvad K, Olsen A, Tjonneland A, et al. Cigar and pipe smoking and cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2010;127: 2402-11.
21. Rostron BL, Chang CM, van Bemmel DM, Xia Y, Blount BC. Nicotine and toxicant exposure among U. S. smokeless tobacco users: results from 1999 to 2012 national health and nutrition examination survey data. Cancer Epidemiol Biomarkers Prev 2015;24:1829-37.
22. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specificNnitrosamines. Chem Res Toxicol 1998;11:559-603.
23. Hecht SS, Carmella SG, Murphy SE, Riley WT, Le C, Luo X, et al. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiol Biomarkers Prev 2007;16: 1567-72.
24. Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 1988;48:6912-17.
25. Hecht SS, Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 1988; 9:875-84.
26. Balbo S, Johnson CS, Kovi RC, James-Yi SA, O'Sullivan MG, Wang M, et al. Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats. Carcinogenesis 2014; 35:2798-806.
27. Accortt NA, Waterbor JW, Beall C, Howard G. Cancer incidence among a cohort of smokeless tobacco users (United States). Cancer Causes Control 2005;16:1107-15.
28. Henley SJ, Thun MJ, Connell C, Calle EE. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 2005;16:347-58.
29. Boffetta P, Aagnes B, Weiderpass E, Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer 2005; 114:992-5.
30. Luo J, Ye W, Zendehdel K, Adami J, Adami H-O, Boffetta P, et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007;369:2015-20.
31. Williams RR, Horm JW. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. J Natl Cancer Inst 1977;58:525-47.
32. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2007;89:1-592.
33. Zheng W, McLaughlin JK, Gridley G, Bjelke E, Schuman LM, Silverman DT, et al. A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control 1993;4:477-82.
34. Alguacil J, Silverman DT. Smokeless and other noncigarette tobacco use and pancreatic cancer: a case-control study based on direct interviews. Cancer Epidemiol Biomarkers Prev 2004;13:55-8.
35. Colilla SA. An epidemiologic review of smokeless tobacco health effects and harm reduction potential. Regul Toxicol Pharmacol 2010;56: 197-211
36. Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol 2008;9:667-75.
37. Lee PN, Hamling J. Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med 2009;7:36.
38. Nordenvall C, Nilsson PJ, Ye W, Nyren O. Smoking, snus use and risk of right-and left-sided colon, rectal and anal cancer: a 37-year follow-up study. Int J Cancer 2011;128:157-65.
39. Motgi AA, Chavan MS, Diwan NN, Chowdhery A, Channe PP, Shete MV. Assessment of cytogenic damage in the form of micronuclei in oral epithelial cells in patients using smokeless and smoked form of tobacco and non-tobacco users and its relevance for oral cancer. J Cancer Res Ther 2014;10:165-70.
40. Balbo S, James-Yi S, Johnson CS, O'SullivanMG, Stepanov I, Wang M, et al. (S)-N'-Nitrosonornicotine, a constituent of smokeless tobacco, is a powerful oral cavity carcinogen in rats. Carcinogenesis 2013;34: 2178-83.
41. Frost-Pineda K, Appleton S, Fisher M, Fox K, Gaworski CL. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction? Nicotine Tob Res 2010;12:1055-67.
42. National Center for Health Statistics. National Health Interview Survey, 2014. Atlanta, GA: Centers for Disease Control and Prevention; 2015. Available from: http://www. cdc. gov/nchs/nhis/quest-data-related- 1997-forward. htm.
43. Burns DM, Major JM, Shanks TG. Changes in number of cigarettes smoked per day: cross-sectional and birth cohort analyses using NHIS. In: Shopland DR, Burns DM, editors. Smoking and Tobacco Control Monograph No. 15: Those Who Continue to Smoke. MD: U. S. Department of Health and Human Services, National Cancer Institute, 2003.
44. Nelson DE, Mowery P, Tomar S, Marcus S, Giovino G, Zhao L. Trends in smokeless tobacco use among adults and adolescents in the United States. Am J Public Health 2006;96:897-905.